Skip to main navigation Skip to search Skip to main content

Provider-led community antiretroviral therapy distribution in Malawi: Retrospective cohort study of retention, viral load suppression and costs

  • John Songo*
  • , Hannah S. Whitehead
  • , Brooke E. Nichols
  • , Amos Makwaya
  • , Joseph Njala
  • , Sam Phiri
  • , Risa M. Hoffman
  • , Kathryn Dovel
  • , Khumbo Phiri
  • , Joep J. van Oosterhout
  • *Corresponding author for this work
  • Partners in Hope
  • University of California at Los Angeles
  • FIND
  • Kamuzu University of Health Sciences

Research output: Contribution to journalArticleAcademicpeer-review

20 Downloads (Pure)

Abstract

Background Outcomes of community antiretroviral therapy (ART) distribution (CAD), in which provider–led ART teams deliver integrated HIV services at health posts in communities, have been mixed in sub-Saharan African countries. CAD outcomes and costs relative to facility-based care have not been reported from Malawi. Methods We performed a retrospective cohort study in two Malawian districts (Lilongwe and Chikwawa districts), comparing CAD with facility-based ART care. We selected an equal number of clients in CAD and facility-based care who were aged >13 years, had an undetectable viral load (VL) result in the last year and were stable on first-line ART for ≥1 year. We compared retention in care (alive and no period of ≥60 days without ART) using Kaplan-Meier survival analysis and Cox regression and maintenance of VL suppression (<1,000 copies/ mL) during follow-up using logistic regression. We also compared costs (in US$) from the health system and client perspectives for the two models of care. Data were collected in October and November 2020. Results 700 ART clients (350 CAD, 350 facility-based) were included. The median age was 43 years (IQR 36–51), median duration on ART was 7 years (IQR 4–9), and 75% were female. Retention in care did not differ significantly between clients in CAD (89.4% retained) and facility-based care (89.3%), p = 0.95. No significant difference in maintenance of VL suppression were observed between CAD and facility-based care (aOR: 1.24, 95% CI: 0.47–3.20, p = 0.70). CAD resulted in slightly higher health system costs than facility-based care: $118/ year vs. $108/year per person accessing care; and $133/year vs. $122/year per person retained in care. CAD decreased individual client costs compared to facility-based care: $3.20/year vs. $11.40/year per person accessing care; and $3.60/year vs. $12.90/year per person retained in care. Conclusion Clients in provider-led CAD care in Malawi had very good retention in care and VL suppression outcomes, similar to clients receiving facility-based care. While health system costs were somewhat higher with CAD, costs for clients were reduced substantially. More research is needed to understand the impact of other differentiated service delivery models on costs for the health system and clients.
Original languageEnglish
Article numbere0002081
JournalPLOS global public health
Volume3
Issue number9
DOIs
Publication statusPublished - 1 Sept 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Provider-led community antiretroviral therapy distribution in Malawi: Retrospective cohort study of retention, viral load suppression and costs'. Together they form a unique fingerprint.

Cite this